Alpha 2.0
Login Register
» Articles » PMID: 29153547

Optimization of Peptide-based Polyagonists for Treatment of Diabetes and Obesity

Overview
Journal Bioorg Med Chem
Specialties Biochemistry
Chemistry
Date 2017 Nov 21
PMID 29153547
Citations 7
Authors
Patrick J Knerr
Brian Finan
Vasily Gelfanov
Diego Perez-Tilve
Matthias H Tschop
Richard D DiMarchi
Affiliations
Soon will be listed here.
Citing Articles

Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice.

Ma J, Hu X, Zhang W, Tao M, Wang M, Lu W Endocrine. 2024; 87(1):159-169.

PMID: 39212900 DOI: 10.1007/s12020-024-03998-8.

[The causes of obesity relapse after weight loss].

Guseinova R, Dorovskikh A, Vasyukova O, Shestakova E, Okorokov P, Mokrysheva N Probl Endokrinol (Mosk). 2024; 70(3):67-73.

PMID: 39069774 PMC: 11334232. DOI: 10.14341/probl13275.

A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes.

Jiang H, Pang S, Zhang Y, Yu T, Liu M, Deng H Nat Commun. 2022; 13(1):3613.

PMID: 35750681 PMC: 9232612. DOI: 10.1038/s41467-022-31328-x.

IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study.

Ji L, Jiang H, An P, Deng H, Liu M, Li L EClinicalMedicine. 2021; 39:101088.

PMID: 34430840 PMC: 8374649. DOI: 10.1016/j.eclinm.2021.101088.

A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.

Ceddia R, Collins S Clin Sci (Lond). 2020; 134(5):473-512.

PMID: 32149342 PMC: 9137350. DOI: 10.1042/CS20190579.